Quantbot Technologies LP - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 79 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,832
-46.3%
800
-42.9%
0.00%
-100.0%
Q3 2022$9,000
-35.7%
1,400
-50.0%
0.00%0.0%
Q2 2022$14,000
-86.3%
2,800
-65.9%
0.00%
-87.5%
Q4 2021$102,000
+1600.0%
8,200
+4000.0%
0.01%
Q3 2021$6,0002000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$69,274,0001.12%
Baker Brothers Advisors 10,123,824$69,854,0000.40%
HHLR ADVISORS, LTD. 583,333$4,025,0000.08%
Rock Springs Capital Management LP 368,959$2,546,0000.06%
PDT Partners, LLC 71,822$496,0000.04%
Virtus ETF Advisers LLC 13,048$90,0000.04%
Corton Capital Inc. 10,918$75,0000.03%
GSA CAPITAL PARTNERS LLP 23,201$160,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 24,238$167,0000.01%
IndexIQ Advisors LLC 56,750$392,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders